Takeda Pharmaceutical’s gout drug Uloric (febuxostat) has been linked to a wide range of adverse events. The company is facing whistleblower lawsuits for downplaying risk information. If you were injured, contact our law firm to learn more about joining a Uloric class action vs. filing an individual lawsuit.
What is Uloric?
Uloric (febuxostat) is a prescription medication for the treatment of gout, a painful type of arthritis that occurs when high levels of uric acid deposit needle-like crystals in the joints, causing inflammation. Uloric treats gout by reducing uric acid levels.
Uloric Class Action Lawsuit Information
Takeda has been hit with a whistleblower lawsuit filed by Dr. Helen Ge, a former safety consultant. She alleges that the company withheld risk information regarding Uloric.
Dr. Ge said that Takeda failed to report that Uloric could interact with several other medications. She also alleges that Uloric side effects may include bone marrow failure, severe bleeding, and kidney failure. This lawsuit is not part of a Uloric class action — it is an individual lawsuit that was filed in federal court in Massachusetts.
- Liver failure
- Kidney damage
- Heart attack
- Immune system disorders
- Allergic reaction (anaphylaxis, rash, Stevens Johnson Syndrome)
- Psychiatric disorders (psychotic behavior, aggressive thoughts)
- Kidney and urinary disorders
- Bone marrow failure
- Severe bleeding
- And more